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Abstract: MicroRNA has been demonstrated to be a viable tool for body fluid identification purposes in forensic case-
work. Stem-loop reverse transcription (slRT) is regularly used for cDNA synthesis from mature miRNA, along with poly-
A tail extension. Both have been used in a forensic context, but no direct comparison has been carried out. It has also not 
been shown whether poly-A tail extension can be used upon DNA extracts, as previously shown with slRT. Blood and sa-
liva samples were collected and underwent DNA extraction with or without on-column DNA digestion. All samples were 
then aliquoted and underwent slRT and poly-A tail extension separately. qPCR was then conducted targeting microRNA 
markers hsa-miR-451 and hsa-miR-205. It was shown that the DNA digestion step did not affect the ability to differentiate 
between blood and saliva. It was also shown that this differentiation was possible using poly-A tail extension, and that 
poly-A tail extension exhibited more amplification than slRT. So whilst the choice of slRT and poly-A tail extension for 
the purpose of forensic body fluid identification is not critical, it may be best to use poly-A tail extension, particularly 
where there are low traces of sample. 
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INTRODUCTION 
Forensic DNA profiling through the fragment analysis of 
short tandem repeats has revolutionised the criminal investi-
gation. However, it is associated with limitations, one of 
which is the association of the DNA profile with the body 
fluid. For example, if it cannot be said that the DNA profile 
obtained from a particular body fluid, then it can be excluded 
as evidence in a court of law. Standard body fluid identifica-
tion techniques have remained relatively unchanged for dec-
ades and there currently exists a major capability gap be-
tween DNA profiling and body fluid identification. There are 
currently a number of strategies to address this, including 
microRNA analysis. 
MicroRNA (miRNA) analysis has been demonstrated to 
be a viable tool for body fluid identification in forensic case 
work [1-4], which provides a much more reliable, robust and 
sensitive assay than is currently available. A full range of 
body fluid markers has been identified [1] and their effec-
tiveness is evaluated in the context of body fluid mixtures [4] 
and alternative end-point analysis, such as capillary electro-
phoresis (CE) [5-7].  
One of the key aspects of miRNA analysis is the cDNA 
synthesis step. In messenger RNA (mRNA) analysis, this is 
carried out using reverse transcription. However, the mature 
miRNA marker can be ~20–26 bp in length. This presents a 
number of problems relating to reverse transcription;  
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namely, lack of binding sites for random primers and low 
melting temperature (due to short fragment size). Conse-
quently, an elongation of the product during cDNA synthesis 
is required, thus giving more bindings sites for subsequent 
PCR and a larger, more thermo-stable, amplicon. 
There are currently two widely used techniques available 
for the production of larger miRNA amplicons; stem-loop 
reverse transcription [8] and poly-A tail extension [9]. Both 
have been utilised for body fluid identification purposes.  
Stem loop reverse transcription (slRT) was proposed by 
Chen et al. in 2005 [8], which partially reversed the biogene-
sis procedure in which the primary microRNA (pri-miRNA) 
is formed into a stem-loop. slRT requires a long primer se-
quence, which is partially self-complimentary; this creates a 
stem-loop structure and a 6 bp overhang. This 6 bp overhang 
can then be designed to hybridise to the 3’ end 6 bp ‘tab’ on 
the mature miRNA sequence. A polymerase such as MMLV 
reverse transcriptase will then extend the 6 bp overhang to 
generate a complimentary copy of the mature miRNA se-
quence. Upon denaturation, the self-complimentary section 
of the stem-loop will unbind and the mature miRNA se-
quence will degrade, resulting in a single first strand consist-
ing of the stem-loop primer sequence and a complimentary 
copy of the miRNA. This first strand then forms the basis of 
the template for cDNA synthesis, utilising a Taqman probe 
complimentary to the mature miRNA sequence and an unla-
belled reverse primer complimentary to the stem-loop primer 
sequence. An alternative version to this was proposed by Li 
et al. in 2014 [6] which utilises an un-labelled forward 
primer, and a labelled reverse probe. 
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Poly A tail extension was proposed by Fu et al. in 2006 
[9], where mature miRNA markers undergo polyadenylation 
by a poly(A) polymerase and then reverse transcribed using 
oligo dT primers. The polyadenylation constructs a ‘poly-A 
tail’. This poly-A tail serves the same function as the stem-
loop primer in slRT.  
Currently, no studies have explored yet whether slRT or 
poly-A tail extension provides a ‘better’ technique for foren-
sic body fluid identification; consequently, this study carries 
out both slRT and poly-A tail extension upon the same sam-
ples in order to determine whether or not the selection has an 
impact on the end result. In addition, this study will build 
upon the study by Omelia et al. [10], in which it was demon-
strated that miRNA could be characterised following solid 
phase DNA extraction, by carrying out a DNA digestion 
step, in order to assess whether or not this has an effect on 
the results. 
MATERIALS AND METHODS 
Marker Selection 
For the purpose of this study hsa-miR-451 and hsa-miR-
205 has been selected as a blood specific miRNA marker and 
a saliva specific miRNA marker, respectively. These markers 
have been repeatedly shown to be stable body fluid specific 
markers by a number of research groups around the world 
[5-7, 11]. Whilst other body fluid specific markers are avail-
able, these two have been the subjects of most researches in 
relation to body fluid identification. 
Sample Preparation 
Body fluids were collected from six healthy volunteers 
with informed consent and ethical approval. Blood was re-
covered via the finger-prick method and spotted on to a ster-
ile swab. Saliva samples were collected using buccal swabs. 
The tips of the swabs were cut and placed into a sterile mi-
crocentrifuge tube for immediate extraction. The volunteers 
provided multiple samples at different times to reflect any 
individual variations. 
MicroRNA Extraction with On-Column DNA Digestion 
Extraction was carried out on all samples using the 
QIAamp DNA mini solid-phase extraction kit (Qiagen, UK), 
as per the manufacturer’s instructions. Omelia et al. had pre-
viously shown that miRNA is retained within the extracts 
[10]. On-column DNA digestion was performed between the 
binding phase and the washing phase of the extraction proto-
col using the TURBO DNA-free Kit (Life Technologies, 
UK). The column was washed with 350 l AW1 buffer, after 
which 100 l DNA digestion mix containing 10 l 10X 
TURBO DNase Buffer and 10 l TURBO™ DNase was 
applied to the column and incubated at 37 ºC for 30 minutes. 
Afterwards, the column was washed with 500 l AW1 and 
the remainder of the manufacturer’s instructions were fol-
lowed. On-column DNA digestion was omitted from a sepa-
rate set of samples. 
cDNA Synthesis Via Stem-Loop Reverse Transcription 
Stem-loop reverse transcription [8] was carried out using 
the stem-loop primer from the Taqman MicroRNA assays 
(Life Technologies, UK) and the Taqman MicroRNA Re-
verse Transcription kit, (Life Technologies, UK) using the 
Veriti Thermocycler (Life Technologies, UK) as per the 
manufacturer’s instructions.  
cDNA Synthesis Via Poly-A Tail Extension 
Poly-A tail extension [9] was carried out using the miS-
cript II Reverse Transcription kit, (Qiagen, UK) following 
the manufacturer’s instructions, along with the HiSpec 
Buffer using a Veriti Thermocycler (Life Technologies, UK). 
Following cDNA synthesis, the product was diluted 1 in 10. 
Quantitative PCR 
The slRT product then underwent qPCR using the for-
ward and reverse primers, and the Taqman probe from the 
Taqman MicroRNA assay along with TaqMan Universal 
PCR Master Mix II, no UNG (Life Technologies, UK) using 
the Qiagen Rotor-Gene Q, following the manufacturer’s rec-
ommended settings. 
The poly-A tail extension product underwent qPCR using 
10X miScript Primer Assays and the miScript SYBR Green 
PCR kit (Qiagen, UK) on the Qiagen Rotor-Gene Q with a 
72-well rotor with 0.1-ml strip tubes and caps, following the 
manufacturer’s recommended settings.  
All samples were run in triplicate and included the full 
range of negative controls. 40 PCR cycles were used for all 
qPCR studies. 
Data Analysis 
Data was analysed using Cq values (40-Cq value). Sig-
nificance was assessed using paired sample T-tests (p < 
0.05).  
RESULTS 
As shown in Fig. (1), there are significantly lower 
amounts of amplification of miR-451 and miR-205 in blood 
and saliva samples that have undergone DNA digestion (p < 
0.01) than those that have not. However, despite the lower 
amplification in digested samples, there is still sufficiently 
high amplification for it to be used. This decrease in amplifi-
cation following DNA digestion may imply that some of the 
products are gDNA. However, lack of significance suggests 
that this is more likely due to the inclusion of the on-column 
DNA digestion step. It should be noted that the DNA diges-
tion kit was not designed for on-column DNA digestion and 
as such is unlikely to be optimised. 
The level of amplification following poly-A tail exten-
sion follows a similar pattern to slRT in that there is no sig-
nificant difference between the amount of amplification be-
tween digested and undigested blood samples (p = 0.055). 
However there, is significantly less miR-205 in digested sa-
liva than there is in undigested saliva (p  0.01). It is possi-
ble that this decrease in amplification is down to the removal 
of gDNA, or it could be due to the presence of the on-
column DNA digestion step. 
Stem-Loop Reverse Transcription vs Poly-A Tail Exten-
sion 
Digested blood and saliva sample then underwent slRT 
and poly-A tail extension prior to qPCR targeting miR-451. 
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Fig. (1). Bar chart showing the detected amplification of miR-451 and miR-205 in blood and saliva samples that have not undergone DNA 
digestion and those that have. All samples in this data set underwent slRT. Error bars represent one standard deviation (n = 72). 
 
 
Fig. (2). Bar chart showing the detected amplification of miR-451 and miR-205 in blood and saliva samples that have not undergone DNA diges-
tion and those that have. All samples in the data set underwent poly-A tail extension. Error bars represent one standard deviation (n = 72).  
 
In all cases, there was significantly more miR-451 in blood 
samples than in saliva samples, as expected (p < 0.01). There 
was also significantly more product following poly-A tail 
extension in both blood and saliva (p < 0.01).  
The same samples also underwent slRT and poly-A tail 
extension followed by qPCR targeting miR-205 in blood and 
saliva. In all cases, there was significantly more miR-205 in 
saliva than in blood, as expected (p < 0.01). It is also ob-
served that there is significantly more product following 
poly-A tail extension than following slRT in both blood and 
saliva (p < 0.01). 
DISCUSSION 
The purpose of this study was three-fold. Firstly, it was 
based on the study by Omelia et al. [10] and verified that the 
miRNA persists following a standard solid phase DNA ex-
traction procedure. Two sets of blood and saliva samples 
underwent a regularly used body fluid identification proce-
dure as detailed in Omelia et al. [10], with one of the sets 
incorporating on-column DNA digestion. It was demon-
strated that miRNA is still detected following DNA extrac-
tion with on-column DNA digestion. The incorporation of 
the DNA digestion step supports the view that miRNA is 
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Fig. (3). Bar chart showing the detected amplification of miR-451 in digested blood and saliva samples following slRT and poly-A tail exten-
sion. Error bars represent one standard deviation (n = 72).  
 
 
Fig. (4). Bar chart showing the detected amplification of miR-205 in blood and saliva following slRT and poly-A tail extension. Error bars 
represent one standard deviation (n = 72).  
 
being detected rather than some variant of gDNA. This pro-
cedure was carried out using both slRT and poly-A tail ex-
tension. Both showed similar levels of performance.  
It was observed that the digested samples had lower am-
plification than the un-digested samples. However, this was 
not significant (p > 0.05) and could be due to the incorpora-
tion of an additional step (on-column digestion).  
The second purpose was to assess whether or not 
miRNA-based body fluid identification could be used fol-
lowing DNA extraction and poly-A tail extension. It was 
demonstrated that there was significantly more miR-451 in 
blood than saliva and significantly more miR-205 in saliva 
than in blood. This indicates that poly-A tail extension is a 
valid reverse transcription step when carrying out miRNA 
analysis upon DNA extracts. 
The third purpose of the study was to assess the perform-
ance of slRT and poly-A tail extension in the context of body 
fluid identification. This was conducted by carrying out both 
the slRT and poly-A tail extension method on the same sam-
ples. The results indicated that both methods were sufficient 
to differentiate between blood and saliva, using miR-451 and 
miR-205. Consequently, the choice of slRT and poly-A tail 
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extension is not a critical decision to make, at least in the 
context of pristine abundant samples. Although both tech-
niques were sufficient for BFID purposes, it seems apparent 
that the use of poly-A tail extension detects significantly 
higher levels of both miR-451 and miR-205 in the samples 
than the use of slRT. However, it does not appear to signifi-
cantly affect the relative difference in expression of the 
markers in their respective body fluids. Consequently, it may 
be more appropriate to use the poly-A tail extension method 
as this technique seems less likely to get ‘drop-outs’ than 
using slRT with low levels of body fluid samples, which can 
be commonly encountered in forensic casework. 
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